Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke
Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Tyler E. Papp(University of Pennsylvania), Sahily Reyes‐Esteves(University of Pennsylvania), Marco E. Zamora(Translational Therapeutics (United States)), Barbara L. Mui(Arbutus Biopharma (Canada)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Raisa Y. Kiseleva(Translational Therapeutics (United States)), Hélène C. Descamps, Vladimir V. Shuvaev(California University of Pennsylvania), Serena Omo‐Lamai(Translational Therapeutics (United States)), Ying K. Tam(Arbutus Biopharma (Canada)), Evguenia Arguiri(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Christoph A. Thaiss(University of Pennsylvania), Hamideh Parhiz(Translational Therapeutics (United States)), Scott E. Kasner, Patrick M. Glassman(Translational Therapeutics (United States)), Tea Shuvaeva(Translational Therapeutics (United States))
Cited by 9
Related Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k